LeMaitre Vascular's EBIT per Share for the
three
months ended in Dec. 2023 was $0.56.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.76.
During the past 12 months, the average EBIT per Share Growth Rate of LeMaitre Vascular was 22.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 6.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 10.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 17.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for LeMaitre Vascular's EBIT per Share or its related term are showing as below:
LMAT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9.9 Med: 9.5 Max: 43.6
Current: 6.3
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of LeMaitre Vascular was 43.60% per year. The lowest was -9.90% per year. And the median was 9.50% per year.
LMAT's 3-Year EBIT Growth Rate is ranked worse than 51.1% of 724
companies
in the Medical Devices & Instruments industry
Industry Median: 6.75
vs LMAT: 6.30
The historical data trend for LeMaitre Vascular's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.76
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular (NAS:LMAT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
LeMaitre Vascular EBIT per Share Related Terms
Thank you for viewing the detailed overview of LeMaitre Vascular's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
LeMaitre Vascular (LeMaitre Vascular) Business Description
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LMAT has been successfully added to your 